Clearside biomedical inc.

Major-Pharmaceuticals

CLSD


900 North Point Parkway
Alpharetta , GA 30005

Executive/
Director

Price

  • Last Close
  • $ 1.01
    $ +0.02 2.02 %
    Aug 29, 2024
  • 52-Week High/Low
  • $2.02 - $0.68
  • YTD
  • -13.7%

  • Trading Volume
  • 2,495
  • Market Cap Full
  • $ 63M
  • Shares Outstanding
  • 62.4M
    Nov 8, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - -11.2% 53.3% 29% -5% -9.9% -16.7% -7.1% 30.8%
Q2 - -3.3% 14.7% 4.2% -28.8% 4% 97.2% -35.8% 7.7% -11.4%
Q3 - 147.5% -4.1% -42.9% -37.8% 8% 24% -23.1% -22.3% -
Q4 - -48.5% -23.3% -82.4% 369% 80.3% -54.5% -0.9% 34.5% -
J F M A M J J A S O N D
2024 6.8% 12% 9.3% -8.5% - - - - - - - -
2023 25.9% -12.1% -16.1% -2.9% 6.9% 3.7% 4.5% -22.2% -4.4% -16.7% 39.3% 15.8%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%-22%-85%189%-11%0%-59%4%-14%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - 0.41 -0.62 -0.45 -0.07 -0.13 -0.13 -0.15
Q2 - 0.62 0.54 -0.65 -0.15 -0.13 -0.11 -0.13 -0.15
Q3 - 0.28 0.72 -0.75 -0.17 -0.05 -0.08 -0.13 -0.15
Q4 - 0.45 0.65 -0.67 -0.04 -0.14 0.33 -0.16 -
A 0 1.4 2.3 -2.7 -0.8 -0.4 0 -0.6 -0.45

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 36 44.9 57.4 60.1 61.4
Jun 31.9 37.6 44.9 57.6 60.2 61.7
Sep 32 37.8 46.3 59.5 60.2 62
Dec 32 41.1 48.4 59.7 60.2 62.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 1 - - 2 -
Total Asset Turnover - 0.7 0.4 0.1 -
Leverage
Debt Ratio - - - 0.2 0.2
Debt – Equity Ratio - - - 0.4 0.4
Interest Coverage -10 1 - -30 -
Equity multiplier 0.1 - - 0.1 -